Impact Factor
4.66
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
15.33
4,076 total citations
h5-index
100
h5 depth signal
Cited share
76.1%
216 of 284
Total citations
4,076
Citation footprint
Metric signal
16.95
External metric anchor
Self-citation
0.6%
26 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
423
United Kingdom
194
Germany
139
France
104
Australia
97
Citing Fields of Research
Diabetes
586
Endocrinology & Metabolism
373
Nutrition & Dietetics
142
Physiology
101
Osteopathies
79
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,903
Articles tracked across the journal lifetime
Indexed publication set
284
216 cited publications
Last 12 months
122
10.2 publications/month
Open access share
4.9%
6 OA publications in the last year
Leading citing country
United States
423 citing publications
Leading citing field
Diabetes
586 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v5,n4, Apr. 2009-
v5,n4, Apr. 2009-
Research Focus & Classification
Indexed Subjects
Diabetes
Endocrinology & Metabolism
Broad Categories
Endocrinology
Diabetes
Endocrinology & Metabolism
MeSH Descriptors
Endocrine System Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s41574-026-01316-y
Open DOI
The genome-wide puzzle: utilizing GWAS to unveil the genetic architecture of polyendocrine metabolic ovarian syndrome
02
DOI 10.1038/s41574-026-01319-9
Open DOI
A new role in lipid metabolism for an orphan transporter
03
DOI 10.1038/s41574-026-01312-2
Open DOI
The β-cells in type 1 diabetes mellitus: findings from human pancreas studies
Type 1 diabetes mellitus (T1DM) is a chronic autoimmune disease characterized by long-term and dynamic interactions between the immune system and pancreatic β-cells, ultimately leading to severe insulin deficiency. A paradigm shift in T1...
04
DOI 10.1038/s41574-026-01317-x
Open DOI
The immune hub of metabolism: how adipose tissue macrophage infiltration redefined obesity
05
DOI 10.1038/s41574-026-01309-x
Open DOI
Glycation and receptors: coming of AGE in the midst of danger
06
DOI 10.1038/s41574-026-01308-y
Open DOI
Optimizing metabolic health through deep-phenotyping-based personalized nutrition
07
DOI 10.1038/s41574-026-01311-3
Open DOI
Effects of weight cycling in the presence and absence of obesity
08
DOI 10.1038/s41574-026-01313-1
Open DOI
Author Correction: Diagnosis and management of Silver–Russell syndrome: second international consensus statement
09
DOI 10.1038/s41574-026-01310-4
Open DOI
Adipocyte-derived oxylipin suppresses breast cancer growth
10
DOI 10.1038/s41574-026-01303-3
Open DOI
Diagnosis and management of Silver–Russell syndrome: second international consensus statement
This international Consensus Statement updates 2016 guidelines for diagnosis and management of individuals with Silver–Russell syndrome (SRS), using a Delphi-like process to reach agreement through iterative expert discussions, based on ...
Bibliographical & Catalog Notes
Description based on: Vol. 5, no. 4 (Apr. 2009); title from cover.
Latest issue consulted: Vol. 5, no. 4 (Apr. 2009).
Also issued online.